Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-03-01 @ 12:06 AM
Study NCT ID:
NCT01221103
Status:
UNKNOWN
Last Update Posted:
2011-09-13
First Post:
2010-10-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)
Sponsor:
Southern Europe New Drug Organization
Organization: